ArticlePLoS pathogens2025
The efflux pump SugE2 involved in protection of Salmonella 4,[5],12:i:- against quaternary ammonium salts and inhibition of virulence.
Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Salmonella enterica serovar 4,[5],12:i:-, a monophasic variant of Salmonella Typhimurium, has emerged as a common nontyphoidal Salmonella serotype to cause human foodborne disease, exhibiting antibiotic and multidrug resistance. In this study, we identified the isolates of S. 4,[5],12:i:- resistant to quaternary ammonium compounds (QACs) disinfectants, displaying elevated minimum inhibitory concentration (MIC) values (200 μg/mL) in Mueller-Hinton (MH) broth. The efflux pump SugE1 and SugE2 could be induced by didecyldimethylammonium bromide (DDAB) and found to be indispensable for S. 4,[5],12:i:- resistance to DDAB. The Hoechst 33342 dye accumulation and reduced ethidium bromide efflux in ΔsugE1, ΔsugE2 and ΔsugE1ΔsugE2 further confirmed the efflux function of SugE1 and SugE2. Moreover, DDAB inhibited the expression of Salmonella pathogenicity island 1 (SPI-1) to decrease the adhesion and invasion ability of S. 4,[5],12:i:- in IPEC-J2 cells, whereas the deletion of sugE2 increased the adhesion and invasion ability. In an in vivo mice model, the virulence of ΔsugE2 and ΔsugE1ΔsugE2 mutant strains were enhanced and showed significantly increased bacterial loads in the liver, spleen, and cecum. The ΔsugE2 and ΔsugE1ΔsugE2 mutant strains exhibited an enhanced ability to disrupt the intestinal barrier, leading to systemic infection. Finally, we discovered that intestinal extracts could induce sugE1 and sugE2 expression, subsequently suppressing SPI-1 expression through SugE2, mediating the Salmonella intestinal infection process. In conclusion, our findings provide the pivotal role of the SugE2 efflux pump in conferring resistance to DDAB disinfectants and influencing bacterial virulence in S. 4,[5],12:i:-.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.